Dear [Buyer’s Name],
Greetings from [Company Name], India.
We would like to present [Product Name], containing [API and Strength], in [Dosage Form], for [Approved Indication/Therapeutic Area].
Product Overview
| Product detail |
Information |
| Product name |
[Product Name] |
| Generic name |
[API Name] |
| Strength |
[Strength] |
| Dosage form |
[Tablet/Capsule/Injection/Syrup/etc.] |
| Approved indication |
[Indication] |
| Pack presentation |
[Pack Size] |
| Manufacturing standard |
[WHO-GMP/EU-GMP/Other] |
| Available documentation |
[CTD/ACTD/Dossier/COA/Stability Data] |
The pharmaceutical industry can no longer depend on only a few established medicines. Changing disease patterns, growing treatment expectations and increasing competition make continuous research, portfolio renewal, scientific innovation and timely adoption of better therapies essential.
The larger responsibility of the pharmaceutical industry is to continue advancing towards medicines that can prevent disease, improve treatment outcomes and ultimately help address diseases that are currently considered incurable.
At the same time, newness alone is not enough. A new product creates value only when its information, application and clinical utility are highly relevant to the needs of physicians, patients, healthcare institutions and the target market.
We believe [Product Name] deserves consideration because it addresses [Specific Treatment Need or Market Gap] and offers the following practical value:
- Clinical relevance: [Approved clinical use and suitable patient group]
- Product utility: [Dosage convenience/formulation/administration benefit]
- Patient value: [Adherence, accessibility or treatment-continuity benefit]
- Portfolio relevance: [How it strengthens the buyer’s existing product range]
- Market suitability: [Disease burden, institutional demand or commercial opportunity]
- Supply advantage: [Production capability, pack flexibility or delivery support]
Our communication approach follows the scientific and consultative principles of a Medical Science Liaison—MSL. The purpose is not merely to promote the product, but to present its scientific relevance, technical profile, limitations and practical market application in a clear and responsible manner.
For your evaluation, we can present the available supporting information, including:
- Product specifications and Certificate of Analysis
- Manufacturing and GMP documentation
- Stability data and technical documents
- Regulatory dossier availability
- Packaging and labelling possibilities
- Minimum order quantity and production timeline
- Commercial structure and shipment planning
To discuss the product properly, we propose a 20–30 minute Google Meet or Zoom meeting. During the meeting, we can:
- Present the product’s scientific and therapeutic relevance
- Review its technical and quality documentation
- Explain its practical value for [Target Country/Market]
- Discuss registration, packaging and supply possibilities
- Clarify technical or commercial questions directly with the relevant team
Kindly share two suitable meeting slots, along with your time zone, and confirm whether you prefer Google Meet or Zoom. We will arrange the meeting accordingly and share the presentation agenda in advance.
We look forward to a focused and meaningful discussion on [Product Name].
Warm regards,
[Your Full Name]
[Designation]
[Company Name]
India
Mobile/WhatsApp: [Number]
Email: [Email Address]
Website: [Website]